Pregabalin — research review 2

...and this particular calcium channel, the alpha-2-delta, is where pregabalin acts. It's often prescribed for neuropathic pain or fibromyalgia.

Right, and the intriguing part for our discussion on aging and mortality isn't necessarily the channel itself, but the pain it modulates, and the drugs used to do so. Unrelieved chronic pain is a significant stressor.

Absolutely. There’s compelling evidence that chronic pain, particularly through this system, can accelerate biological aging. A study in GeroScience in 2025, for example, found that painful diabetic neuropathy was associated with accelerated epigenetic aging and telomere shortening compared to painless neuropathy.

So, if pregabalin effectively reduces severe chronic pain, it could, in theory, mitigate some of that accelerated aging burden, couldn't it?

It's a reasonable hypothesis. Reducing chronic pain is clearly beneficial for quality of life, and potentially for long-term health markers, but linking pregabalin directly to improved longevity or reduced all-cause mortality due to this specific mechanism is still uncertain. We don't have direct, long-term human outcome studies showing pregabalin itself reduces all-cause mortality.

And what about the risks? We know all medications have potential side effects.

Exactly. While pregabalin is generally safe when prescribed appropriately, like any medication acting on the central nervous system, it carries risks. Drowsiness, dizziness, and in some populations, a risk of dependence or respiratory depression when combined with other central nervous system depressants.

So, it's a balance. The potential benefit of pain relief and its downstream effects on biological aging versus the known risks of the medication, with direct mortality impacts still largely unproven.

Precisely. It genuinely benefits those struggling with severe, specific pain conditions, but the long-term safety and all-cause mortality picture, especially regarding its aging effects, still requires more research beyond observational links.